. . . . . . . "[Despite new insights into mechanisms of anti-endocrine therapy resistance, e.g., crosstalk between ER? and Her2/neu, the management of advanced hormone-receptor-positive breast cancers that are resistant to anti-endocrine agents remains a significant challenge.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:22+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .